<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01511237</url>
  </required_header>
  <id_info>
    <org_study_id>PHPT-5 Second Phase</org_study_id>
    <secondary_id>R01HD052461</secondary_id>
    <secondary_id>R01HD056953</secondary_id>
    <nct_id>NCT01511237</nct_id>
  </id_info>
  <brief_title>Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers</brief_title>
  <acronym>PHPT-5</acronym>
  <official_title>PHPT-5 Second Phase: Perinatal Antiretroviral Intensification for the Prevention of Mother-to-child Transmission of HIV in Thai Women Having Received Less Than 8 Weeks of HAART During Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut de Recherche pour le Developpement</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Harvard School of Public Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut de Recherche pour le Developpement</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to evaluate the efficacy of maternal and infant perinatal antiretroviral
      prophylaxis intensification for the prevention of mother-to-child intrapartum transmission of
      HIV-1 in women receiving less than 8 weeks of antiretroviral prophylaxis during pregnancy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design: a multicenter, phase III, single-arm trial.

      Perinatal antiretroviral intensification (study treatment) is defined as the addition to the
      standard of care* for mothers and infants of:

        -  Mothers: One NVP 200 mg tablet at onset of labor with continuation of HAART for four
           weeks postpartum

        -  Newborn: AZT+3TC+ NVP for 2 weeks, followed by AZT+3TC for 2 weeks:

             -  NVP syrup 2 mg/kg every 24 hours for seven days, followed by NVP syrup 4 mg/kg
                every 24 hours for seven days. Newborns less than 2500 g will be administered
                2mg/kg NVP syrup at each intake

             -  AZT syrup 4 mg/ kg will be given every 12 hours for four weeks (preterm infants
                less than 30 weeks will be administered 2 mg/kg every 12 hours; preterm 30-35 weeks
                will receive 2 mg/kg every 12 hours for the first 2 weeks, increased to 3 mg/kg for
                the next 2 weeks).

             -  3TC syrup 2 mg/kg every 12 hours for four weeks.

                  -  The standard of care in Thailand is defined as:

        -  Maternal antiretroviral treatment: ZDV 300 mg, 3TC 150mg and LPV/r 400/100 twice a day
           starting as soon possible after 14 weeks of pregnancy + ZDV 300 mg every 3 hours during
           labor; this treatment may be continued, stopped or modified after delivery upon the
           recommendation of the internist.

        -  Newborn: ZDV 4 mg/kg every 12 hours for 4 weeks (ZDV dosing adjusted for premature
           infants).
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of perinatal HIV transmission</measure>
    <time_frame>6 months</time_frame>
    <description>HIV DNA PCR analysis at birth, 2 weeks, 1, 2, 4 and 6 months of age</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety for women and neonates</measure>
    <time_frame>Up to 12 Months</time_frame>
    <description>All grade 3 and 4 clinical adverse events and abnormal laboratory values in women will be recorded and graded according to the toxicity tables developed by the DAIDS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregnancy outcomes</measure>
    <time_frame>Up to 12 Months</time_frame>
    <description>Evaluation of the rates of live births and stillbirths, as well as birth weight, gestational age at delivery according to the results of the sonogram at first prenatal visit, newborn maturity (Ballard score).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1837</enrollment>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>Perinatal intensification</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Perinatal antiretroviral intensification (study treatment):
Mothers: One NVP 200 mg tablet at onset of labor with continuation of HAART for four weeks postpartum
Newborn: AZT+3TC+ NVP for 2 weeks, followed by AZT+3TC for 2 weeks
The standard of care in Thailand is defined as:
Maternal: ZDV 300 mg, 3TC 150mg and LPV/r 400/100 twice a day starting as soon possible after 14 weeks of pregnancy + ZDV 300 mg every 3 hours during labor
Newborn: ZDV 4 mg/kg every 12 hours for 4 weeks (ZDV dosing adjusted for premature infants).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nevirapine, zidovudine, lamivudine</intervention_name>
    <description>Mothers: One NVP 200 mg tablet at onset of labor with continuation of HAART for four weeks postpartum
Newborn: AZT+3TC+ NVP for 2 weeks, followed by AZT+3TC for 2 weeks:
NVP syrup 2 mg/kg every 24 hours for seven days, followed by NVP syrup 4 mg/kg every 24 hours for seven days. Newborns less than 2500 g will be administered 2mg/kg NVP syrup at each intake
AZT syrup 4 mg/ kg will be given every 12 hours for four weeks (preterm infants less than 30 weeks will be administered 2 mg/kg every 12 hours; preterm 30-35 weeks will receive 2 mg/kg every 12 hours for the first 2 weeks, increased to 3 mg/kg for the next 2 weeks).
3TC syrup 2 mg/kg every 12 hours for four weeks.</description>
    <arm_group_label>Perinatal intensification</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Eligibility. Pregnant women presenting at the prenatal clinics will be eligible if they are
        confirmed HIV-infected, intend to deliver and bring their infant to a study site for
        postnatal care for at least 6 months; at least 18 years old; and have given written
        informed consent to participate in the study, regardless of their CD4 cell count.

        Maternal inclusion criteria:

          -  Evidence of HIV infection, as documented by two serology tests obtained at two
             different dates;

          -  All HIV infected pregnant women will be enrolled, either in the intervention arm or an
             observational study group.

               -  Women more than 30 weeks gestational age at start of antiretroviral treatment
                  will be eligible for the intervention. They will actually receive the study
                  intervention if they present in labor after less than 8 weeks of treatment
                  duration;

               -  Women with no ANC will receive standard care and will be enrolled in an
                  observational study group(and their infant will receive standard of care
                  perinatal antiretroviral intensification)

               -  Women with less than 30 weeks gestational age at start of treatment will receive
                  standard care and will also be enrolled in the Observational Reference group;

          -  Agreement not to breastfeed;

          -  Consent to participate and to be followed for the duration of the study

        Exclusion Criteria:

          -  Evidence of pre-existing fetal anomalies incompatible with life;

          -  Concurrent participation to any other clinical trial without prior agreement of the
             two study teams
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Lallemant, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut de Recherche pour le Developpment</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Health Promotion Hospital Regional Center I</name>
      <address>
        <city>Bangkean</city>
        <state>Bangkok</state>
        <zip>10220</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nopparat Rajathanee Hospital</name>
      <address>
        <city>Kannayao</city>
        <state>Bangkok</state>
        <zip>10230</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bhumibol Adulyadej Hospital</name>
      <address>
        <city>Saimai</city>
        <state>Bangkok</state>
        <zip>10220</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bhuddasothorn Hospital</name>
      <address>
        <city>Muang</city>
        <state>Chachoengsao</state>
        <zip>24000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prapokklao Hospital</name>
      <address>
        <city>Muang</city>
        <state>Chantaburi</state>
        <zip>22000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chomthong Hospital</name>
      <address>
        <city>Chomthong</city>
        <state>Chiang Mai</state>
        <zip>50160</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fang Hospital</name>
      <address>
        <city>Fang</city>
        <state>Chiang Mai</state>
        <zip>50110</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nakornping Hospital</name>
      <address>
        <city>Mae Rim</city>
        <state>Chiang Mai</state>
        <zip>50180</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Promotion Center Region 10, Chiang Mai</name>
      <address>
        <city>Muang</city>
        <state>Chiang Mai</state>
        <zip>50100</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanpatong Hospital</name>
      <address>
        <city>Sanpatong</city>
        <state>Chiang Mai</state>
        <zip>50120</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mae Chan Hospital</name>
      <address>
        <city>Mae Chan</city>
        <state>Chiang Rai</state>
        <zip>57110</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mae Sai Hospital</name>
      <address>
        <city>Mae Sai</city>
        <state>Chiang Rai</state>
        <zip>57130</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phan Hospital</name>
      <address>
        <city>Phan</city>
        <state>Chiang Rai</state>
        <zip>57120</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chiang Saen Hospital</name>
      <address>
        <city>Chiang Saen</city>
        <state>Chiangrai</state>
        <zip>57150</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chiangrai Prachanukroh Hospital</name>
      <address>
        <city>Muang</city>
        <state>Chiangrai</state>
        <zip>57000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wiangpapao Hospital</name>
      <address>
        <city>Wiangpapao</city>
        <state>Chiangrai</state>
        <zip>57170</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Banglamung Hospital</name>
      <address>
        <city>Banglamung</city>
        <state>Chonburi</state>
        <zip>20150</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chonburi Hospital</name>
      <address>
        <city>Muang</city>
        <state>Chonburi</state>
        <zip>20000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Panasnikom Hospital</name>
      <address>
        <city>Panasnikom</city>
        <state>Chonburi</state>
        <zip>20140</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kalasin Hospital</name>
      <address>
        <city>Muang</city>
        <state>Kalasin</state>
        <zip>46000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Khon Kaen Hospital</name>
      <address>
        <city>Muang</city>
        <state>Khon Kaen</state>
        <zip>40000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Health Promotion Centre 6, Khon Kaen</name>
      <address>
        <city>Muang</city>
        <state>Khon Kaen</state>
        <zip>40000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lampang Hospital</name>
      <address>
        <city>Muang</city>
        <state>Lampang</state>
        <zip>52000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lamphun Hospital</name>
      <address>
        <city>Muang</city>
        <state>Lamphun</state>
        <zip>51000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mahasarakam Hospital</name>
      <address>
        <city>Muang</city>
        <state>Mahasarakam</state>
        <zip>44000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maharaj Nakhon Si Thammarat Hospital</name>
      <address>
        <city>Muang</city>
        <state>Nakhon Si Thammarat</state>
        <zip>80000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nakhonpathom Hospital</name>
      <address>
        <city>Muang</city>
        <state>Nakhonpathom</state>
        <zip>73000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nong Khai Hospital</name>
      <address>
        <city>Muang</city>
        <state>Nong Khai</state>
        <zip>43000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pranangklao Hospital</name>
      <address>
        <city>Muang</city>
        <state>Nonthaburi</state>
        <zip>11000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chiang Kham Hospital</name>
      <address>
        <city>Chiang Kham</city>
        <state>Phayao</state>
        <zip>56110</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phayao Provincial Hospital</name>
      <address>
        <city>Muang</city>
        <state>Phayao</state>
        <zip>56000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vachira Phuket Hospital</name>
      <address>
        <city>Muang</city>
        <state>Phuket</state>
        <zip>83000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Buddhachinaraj Hospital</name>
      <address>
        <city>Muang</city>
        <state>Pitsanuloke</state>
        <zip>65000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rayong Hospital</name>
      <address>
        <city>Muang</city>
        <state>Rayong</state>
        <zip>21000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samutprakarn Hospital</name>
      <address>
        <city>Muang</city>
        <state>Samutprakarn</state>
        <zip>10280</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samutsakhon Hospital</name>
      <address>
        <city>Muang</city>
        <state>Samutsakhon</state>
        <zip>74000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Songkhla Hospital</name>
      <address>
        <city>Muangsongkhla</city>
        <state>Songkhla</state>
        <zip>90100</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hat Yai Hospital</name>
      <address>
        <city>Hat Yai</city>
        <state>Songkla</state>
        <zip>90110</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <link>
    <url>http://www.clinicaltrials.gov/ct2/show/NCT00409591</url>
    <description>PHPT-5 First Phase</description>
  </link>
  <results_reference>
    <citation>Lallemant Marc, Amzal Billy, Urien Saik, Sripan Patumrat, Cressey Tim R, Ngo-Giang-Huong Nicole, Rawangban Boonsong, Sabsanong Prapan, Siriwachirachai Thitiporn, Jarupanich Tapnarong, Kanjanavikai Prateep, Wanasiri Phaiboon, Koetsawang Suporn, Jourdain Gonzague, Le CÅ“ur Sophie, for the PHPT-5 team. 2015. -&quot;Antiretroviral Intensification to Prevent Intrapartum HIV Transmission in Late Comers&quot;. 8th IAS Conference on HIV Pathogenesis Treatment &amp; Prevention, Vancouver, Canada, 19-22 July 2015.</citation>
  </results_reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2012</study_first_submitted>
  <study_first_submitted_qc>January 12, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2012</study_first_posted>
  <last_update_submitted>November 7, 2016</last_update_submitted>
  <last_update_submitted_qc>November 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut de Recherche pour le Developpement</investigator_affiliation>
    <investigator_full_name>Marc Lallemant</investigator_full_name>
    <investigator_title>Senior Researcher</investigator_title>
  </responsible_party>
  <keyword>HIV-1 infection</keyword>
  <keyword>Prophylaxis</keyword>
  <keyword>Mother-to-child transmission HIV-1</keyword>
  <keyword>Thailand</keyword>
  <keyword>Developing Countries</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lamivudine</mesh_term>
    <mesh_term>Zidovudine</mesh_term>
    <mesh_term>Nevirapine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

